← Open Payments lookup

FUNMILAYO AKINRIMISI: Open Payments

NPI 1184281560 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,252 in 51 payments from 9 companies in 2025. Trend: 2023 $261 · 2024 $153 · 2025 $1,252

Food & beverage: $1,252
CompanyPaymentsAmount
Alkermes, Inc.10$366
Otsuka America Pharmaceutical, Inc.9$243
Janssen Pharmaceuticals, Inc8$207
Teva Pharmaceuticals USA, Inc.12$184
Luye Pharma (USA) Ltd.3$85
E.R. Squibb & Sons, L.L.C.4$79
Neurocrine BioSciences, Inc.2$42
Supernus Pharmaceuticals, Inc.2$32
Lundbeck LLC1$14

Products named: LYBALVI, INVEGA SUSTENNA, ARISTADA, ABILIFY MAINTENA, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE.

Industry payments across TX — which companies pay providers there.